Structure

Physi-Chem Properties

Molecular Weight:  550.21
Volume:  522.43
LogP:  0.809
LogD:  1.415
LogS:  -4.002
# Rotatable Bonds:  8
TPSA:  165.76
# H-Bond Aceptor:  12
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.312
Synthetic Accessibility Score:  4.549
Fsp3:  0.556
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.172
MDCK Permeability:  3.2934825867414474e-05
Pgp-inhibitor:  0.046
Pgp-substrate:  0.992
Human Intestinal Absorption (HIA):  0.22
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.252

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.17
Plasma Protein Binding (PPB):  43.793270111083984%
Volume Distribution (VD):  0.305
Pgp-substrate:  21.769922256469727%

ADMET: Metabolism

CYP1A2-inhibitor:  0.011
CYP1A2-substrate:  0.807
CYP2C19-inhibitor:  0.009
CYP2C19-substrate:  0.812
CYP2C9-inhibitor:  0.007
CYP2C9-substrate:  0.251
CYP2D6-inhibitor:  0.024
CYP2D6-substrate:  0.305
CYP3A4-inhibitor:  0.061
CYP3A4-substrate:  0.399

ADMET: Excretion

Clearance (CL):  3.982
Half-life (T1/2):  0.456

ADMET: Toxicity

hERG Blockers:  0.634
Human Hepatotoxicity (H-HT):  0.195
Drug-inuced Liver Injury (DILI):  0.266
AMES Toxicity:  0.085
Rat Oral Acute Toxicity:  0.046
Maximum Recommended Daily Dose:  0.207
Skin Sensitization:  0.929
Carcinogencity:  0.053
Eye Corrosion:  0.003
Eye Irritation:  0.021
Respiratory Toxicity:  0.3

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC55158

Natural Product ID:  NPC55158
Common Name*:   (+)-Eucommin A
IUPAC Name:   (2S,3R,4S,5S,6R)-2-[4-[(3S,3aR,6S,6aR)-3-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Synonyms:   (+)-Eucommin A
Standard InCHIKey:  GLGVEKKQPFRBAS-UOVCOODASA-N
Standard InCHI:  InChI=1S/C27H34O12/c1-33-17-6-12(4-5-16(17)29)24-14-10-37-25(15(14)11-36-24)13-7-18(34-2)26(19(8-13)35-3)39-27-23(32)22(31)21(30)20(9-28)38-27/h4-8,14-15,20-25,27-32H,9-11H2,1-3H3/t14-,15-,20+,21+,22-,23+,24+,25+,27-/m0/s1
SMILES:  OC[C@H]1O[C@@H](Oc2c(OC)cc(cc2OC)[C@H]2OC[C@H]3[C@@H]2CO[C@@H]3c2ccc(c(c2)OC)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1076999
PubChem CID:   442836
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001511] Lignan glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18521 Capparis flavicans Species Capparaceae Eukaryota aerial parts Khon Kaen Province, Thailand 2006-Aug PMID[19943620]
NPO16850 Eucommia ulmoides Species Eucommiaceae Eukaryota n.a. bark n.a. PMID[26767291]
NPO16850 Eucommia ulmoides Species Eucommiaceae Eukaryota n.a. n.a. n.a. PMID[26767291]
NPO16850 Eucommia ulmoides Species Eucommiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16850 Eucommia ulmoides Species Eucommiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16850 Eucommia ulmoides Species Eucommiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16850 Eucommia ulmoides Species Eucommiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO18521 Capparis flavicans Species Capparaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16850 Eucommia ulmoides Species Eucommiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens Activity < 0.1 uM PMID[522912]
NPT83 Cell Line MCF7 Homo sapiens Activity > 100.0 uM PMID[522912]
NPT396 Cell Line T47D Homo sapiens Activity < 0.1 uM PMID[522912]
NPT396 Cell Line T47D Homo sapiens Activity = 2.0 uM PMID[522912]
NPT396 Cell Line T47D Homo sapiens Activity > 100.0 uM PMID[522912]
NPT83 Cell Line MCF7 Homo sapiens Inhibition > 90.0 % PMID[522912]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC55158 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC51328
1.0 High Similarity NPC286235
0.9929 High Similarity NPC130449
0.9929 High Similarity NPC248132
0.9858 High Similarity NPC39657
0.9716 High Similarity NPC279298
0.9716 High Similarity NPC22150
0.9716 High Similarity NPC38041
0.9648 High Similarity NPC112861
0.9645 High Similarity NPC472712
0.9645 High Similarity NPC472713
0.9645 High Similarity NPC187774
0.9645 High Similarity NPC118385
0.9645 High Similarity NPC473046
0.9577 High Similarity NPC18979
0.9574 High Similarity NPC477898
0.9574 High Similarity NPC470950
0.9574 High Similarity NPC185307
0.9517 High Similarity NPC472710
0.9517 High Similarity NPC472709
0.9507 High Similarity NPC283995
0.9507 High Similarity NPC470235
0.9507 High Similarity NPC25292
0.9507 High Similarity NPC129417
0.9507 High Similarity NPC84181
0.9507 High Similarity NPC473045
0.9504 High Similarity NPC472714
0.9504 High Similarity NPC5262
0.9504 High Similarity NPC189115
0.9504 High Similarity NPC246947
0.9504 High Similarity NPC476356
0.9504 High Similarity NPC469559
0.9448 High Similarity NPC95392
0.9448 High Similarity NPC35877
0.9448 High Similarity NPC55715
0.9441 High Similarity NPC475096
0.9437 High Similarity NPC473044
0.9437 High Similarity NPC46092
0.9433 High Similarity NPC472711
0.9433 High Similarity NPC469661
0.9384 High Similarity NPC475224
0.9384 High Similarity NPC98624
0.9379 High Similarity NPC166584
0.9379 High Similarity NPC270751
0.9379 High Similarity NPC301961
0.9375 High Similarity NPC99515
0.9375 High Similarity NPC190714
0.9371 High Similarity NPC470097
0.9371 High Similarity NPC471415
0.9371 High Similarity NPC114119
0.9362 High Similarity NPC177868
0.9362 High Similarity NPC226547
0.931 High Similarity NPC213074
0.931 High Similarity NPC227902
0.931 High Similarity NPC193473
0.931 High Similarity NPC275284
0.931 High Similarity NPC114505
0.931 High Similarity NPC224674
0.931 High Similarity NPC31325
0.931 High Similarity NPC15956
0.9306 High Similarity NPC469586
0.9301 High Similarity NPC185071
0.9301 High Similarity NPC12728
0.9301 High Similarity NPC298317
0.9301 High Similarity NPC255566
0.9291 High Similarity NPC98777
0.9291 High Similarity NPC156376
0.9291 High Similarity NPC212770
0.9252 High Similarity NPC238140
0.9247 High Similarity NPC175976
0.9241 High Similarity NPC276753
0.9241 High Similarity NPC324492
0.9241 High Similarity NPC212890
0.9241 High Similarity NPC226540
0.9241 High Similarity NPC205796
0.9241 High Similarity NPC317053
0.9241 High Similarity NPC125755
0.9231 High Similarity NPC475084
0.9231 High Similarity NPC302506
0.922 High Similarity NPC185908
0.922 High Similarity NPC283949
0.922 High Similarity NPC470413
0.922 High Similarity NPC65530
0.922 High Similarity NPC59324
0.922 High Similarity NPC138738
0.922 High Similarity NPC474039
0.9178 High Similarity NPC320671
0.9178 High Similarity NPC328567
0.9178 High Similarity NPC327412
0.9178 High Similarity NPC320970
0.9172 High Similarity NPC477702
0.9172 High Similarity NPC43508
0.9172 High Similarity NPC474749
0.9172 High Similarity NPC161700
0.9172 High Similarity NPC277867
0.9172 High Similarity NPC178014
0.9172 High Similarity NPC42716
0.9172 High Similarity NPC11422
0.9172 High Similarity NPC180953
0.9172 High Similarity NPC307466
0.9172 High Similarity NPC476301
0.9167 High Similarity NPC81638
0.9161 High Similarity NPC471908
0.9149 High Similarity NPC52277
0.9149 High Similarity NPC242028
0.9149 High Similarity NPC172818
0.9149 High Similarity NPC203230
0.9149 High Similarity NPC25695
0.9149 High Similarity NPC177035
0.9149 High Similarity NPC199459
0.9133 High Similarity NPC159922
0.9128 High Similarity NPC302610
0.9116 High Similarity NPC304048
0.9116 High Similarity NPC226153
0.9116 High Similarity NPC71726
0.911 High Similarity NPC162193
0.9103 High Similarity NPC79429
0.9103 High Similarity NPC168579
0.9103 High Similarity NPC471667
0.9103 High Similarity NPC471063
0.9103 High Similarity NPC76176
0.9103 High Similarity NPC469313
0.9103 High Similarity NPC179521
0.9103 High Similarity NPC138227
0.9103 High Similarity NPC217635
0.9091 High Similarity NPC56091
0.9091 High Similarity NPC184797
0.9091 High Similarity NPC46591
0.9091 High Similarity NPC266197
0.9091 High Similarity NPC309124
0.9091 High Similarity NPC106944
0.9091 High Similarity NPC291101
0.9085 High Similarity NPC195196
0.9078 High Similarity NPC101624
0.9078 High Similarity NPC184938
0.9078 High Similarity NPC150534
0.9078 High Similarity NPC236522
0.9078 High Similarity NPC34103
0.9078 High Similarity NPC142547
0.9078 High Similarity NPC165155
0.9078 High Similarity NPC99572
0.9078 High Similarity NPC126409
0.9078 High Similarity NPC141765
0.9078 High Similarity NPC24490
0.9078 High Similarity NPC135777
0.9054 High Similarity NPC470098
0.9054 High Similarity NPC470826
0.9054 High Similarity NPC106138
0.9054 High Similarity NPC473266
0.9048 High Similarity NPC473480
0.9048 High Similarity NPC15538
0.9038 High Similarity NPC59516
0.9034 High Similarity NPC278961
0.9034 High Similarity NPC113680
0.9034 High Similarity NPC252169
0.9034 High Similarity NPC474808
0.9034 High Similarity NPC37793
0.9021 High Similarity NPC232164
0.9021 High Similarity NPC236306
0.9021 High Similarity NPC88640
0.9021 High Similarity NPC193666
0.9021 High Similarity NPC123526
0.9021 High Similarity NPC292487
0.9021 High Similarity NPC473739
0.9014 High Similarity NPC164857
0.9013 High Similarity NPC11411
0.9007 High Similarity NPC187194
0.9007 High Similarity NPC13745
0.9007 High Similarity NPC251981
0.9007 High Similarity NPC244983
0.9007 High Similarity NPC107478
0.9007 High Similarity NPC170694
0.9007 High Similarity NPC287745
0.9007 High Similarity NPC476411
0.9007 High Similarity NPC326095
0.9007 High Similarity NPC48863
0.9 High Similarity NPC21902
0.8993 High Similarity NPC225815
0.8993 High Similarity NPC145979
0.8993 High Similarity NPC185955
0.8993 High Similarity NPC214326
0.8993 High Similarity NPC469706
0.8993 High Similarity NPC9933
0.8993 High Similarity NPC260781
0.8993 High Similarity NPC218041
0.8993 High Similarity NPC182368
0.8993 High Similarity NPC469707
0.8986 High Similarity NPC280945
0.898 High Similarity NPC260397
0.898 High Similarity NPC241846
0.898 High Similarity NPC93610
0.8966 High Similarity NPC107161
0.8966 High Similarity NPC287124
0.8966 High Similarity NPC80326
0.8966 High Similarity NPC253878
0.8958 High Similarity NPC55793
0.8951 High Similarity NPC304152
0.8944 High Similarity NPC470236
0.894 High Similarity NPC61604
0.894 High Similarity NPC115466

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC55158 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8652 High Similarity NPD3027 Phase 3
0.8625 High Similarity NPD7228 Approved
0.8601 High Similarity NPD1612 Clinical (unspecified phase)
0.8601 High Similarity NPD1613 Approved
0.8535 High Similarity NPD6234 Discontinued
0.8408 Intermediate Similarity NPD4965 Approved
0.8408 Intermediate Similarity NPD4967 Phase 2
0.8408 Intermediate Similarity NPD4966 Approved
0.8322 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8312 Intermediate Similarity NPD1653 Approved
0.8252 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD37 Approved
0.8199 Intermediate Similarity NPD7199 Phase 2
0.8182 Intermediate Similarity NPD7074 Phase 3
0.8171 Intermediate Similarity NPD3818 Discontinued
0.8146 Intermediate Similarity NPD6674 Discontinued
0.8133 Intermediate Similarity NPD7266 Discontinued
0.8121 Intermediate Similarity NPD7054 Approved
0.8084 Intermediate Similarity NPD7240 Approved
0.8072 Intermediate Similarity NPD7472 Approved
0.7988 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7945 Intermediate Similarity NPD4908 Phase 1
0.787 Intermediate Similarity NPD7251 Discontinued
0.7838 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7832 Intermediate Similarity NPD3705 Approved
0.7832 Intermediate Similarity NPD1610 Phase 2
0.7832 Intermediate Similarity NPD1091 Approved
0.7824 Intermediate Similarity NPD7808 Phase 3
0.7811 Intermediate Similarity NPD6797 Phase 2
0.7764 Intermediate Similarity NPD1934 Approved
0.7755 Intermediate Similarity NPD2861 Phase 2
0.7719 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7709 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD6559 Discontinued
0.7643 Intermediate Similarity NPD5058 Phase 3
0.7637 Intermediate Similarity NPD7680 Approved
0.763 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD1357 Approved
0.7622 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6166 Phase 2
0.7607 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD7685 Pre-registration
0.75 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3620 Phase 2
0.7485 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD4749 Approved
0.7483 Intermediate Similarity NPD2982 Phase 2
0.7483 Intermediate Similarity NPD2983 Phase 2
0.747 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD5283 Phase 1
0.7431 Intermediate Similarity NPD1548 Phase 1
0.7417 Intermediate Similarity NPD4625 Phase 3
0.7415 Intermediate Similarity NPD2981 Phase 2
0.741 Intermediate Similarity NPD3882 Suspended
0.74 Intermediate Similarity NPD3018 Phase 2
0.7394 Intermediate Similarity NPD2801 Approved
0.7394 Intermediate Similarity NPD2977 Approved
0.7394 Intermediate Similarity NPD2978 Approved
0.7394 Intermediate Similarity NPD8455 Phase 2
0.7362 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD7157 Approved
0.7342 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD5735 Approved
0.7308 Intermediate Similarity NPD5588 Approved
0.7305 Intermediate Similarity NPD228 Approved
0.7283 Intermediate Similarity NPD5844 Phase 1
0.7278 Intermediate Similarity NPD5494 Approved
0.7273 Intermediate Similarity NPD4060 Phase 1
0.7254 Intermediate Similarity NPD7843 Approved
0.7246 Intermediate Similarity NPD3817 Phase 2
0.7244 Intermediate Similarity NPD4536 Approved
0.7244 Intermediate Similarity NPD4538 Approved
0.7244 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD3382 Approved
0.7229 Intermediate Similarity NPD3384 Approved
0.7229 Intermediate Similarity NPD3383 Approved
0.7215 Intermediate Similarity NPD1375 Discontinued
0.7211 Intermediate Similarity NPD5125 Phase 3
0.7211 Intermediate Similarity NPD5126 Approved
0.7207 Intermediate Similarity NPD6842 Approved
0.7207 Intermediate Similarity NPD6843 Phase 3
0.7207 Intermediate Similarity NPD6841 Approved
0.72 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD1465 Phase 2
0.7163 Intermediate Similarity NPD3021 Approved
0.7163 Intermediate Similarity NPD3022 Approved
0.7161 Intermediate Similarity NPD1558 Phase 1
0.716 Intermediate Similarity NPD1511 Approved
0.716 Intermediate Similarity NPD7075 Discontinued
0.7143 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7097 Phase 1
0.7133 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD1652 Phase 2
0.7115 Intermediate Similarity NPD5124 Phase 1
0.7115 Intermediate Similarity NPD6355 Discontinued
0.7115 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD4380 Phase 2
0.7108 Intermediate Similarity NPD4675 Approved
0.7108 Intermediate Similarity NPD4678 Approved
0.7107 Intermediate Similarity NPD5762 Approved
0.7107 Intermediate Similarity NPD5763 Approved
0.7105 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD3787 Discontinued
0.7092 Intermediate Similarity NPD2684 Approved
0.7089 Intermediate Similarity NPD4108 Discontinued
0.7089 Intermediate Similarity NPD5960 Phase 3
0.7086 Intermediate Similarity NPD8651 Approved
0.7081 Intermediate Similarity NPD6331 Phase 2
0.7081 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD4110 Phase 3
0.7078 Intermediate Similarity NPD7095 Approved
0.7073 Intermediate Similarity NPD1512 Approved
0.707 Intermediate Similarity NPD6653 Approved
0.7069 Intermediate Similarity NPD7473 Discontinued
0.7048 Intermediate Similarity NPD4005 Discontinued
0.7044 Intermediate Similarity NPD6100 Approved
0.7044 Intermediate Similarity NPD6099 Approved
0.7041 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD6190 Approved
0.7035 Intermediate Similarity NPD8127 Discontinued
0.7022 Intermediate Similarity NPD7549 Discontinued
0.7019 Intermediate Similarity NPD5177 Phase 3
0.7019 Intermediate Similarity NPD4236 Phase 3
0.7019 Intermediate Similarity NPD4237 Approved
0.7017 Intermediate Similarity NPD7906 Approved
0.7012 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD7447 Phase 1
0.7011 Intermediate Similarity NPD2489 Approved
0.7011 Intermediate Similarity NPD27 Approved
0.7 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.6994 Remote Similarity NPD7124 Phase 2
0.6994 Remote Similarity NPD6232 Discontinued
0.6986 Remote Similarity NPD6671 Approved
0.6983 Remote Similarity NPD8313 Approved
0.6983 Remote Similarity NPD7312 Approved
0.6983 Remote Similarity NPD7311 Approved
0.6983 Remote Similarity NPD8312 Approved
0.6983 Remote Similarity NPD7310 Approved
0.6983 Remote Similarity NPD7313 Approved
0.6982 Remote Similarity NPD5772 Approved
0.6982 Remote Similarity NPD7819 Suspended
0.6982 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6982 Remote Similarity NPD5773 Approved
0.6975 Remote Similarity NPD7466 Approved
0.6975 Remote Similarity NPD3892 Phase 2
0.6975 Remote Similarity NPD4628 Phase 3
0.6975 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6964 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6961 Remote Similarity NPD4663 Approved
0.6954 Remote Similarity NPD2969 Approved
0.6954 Remote Similarity NPD2970 Approved
0.6951 Remote Similarity NPD7213 Phase 3
0.6951 Remote Similarity NPD7212 Phase 2
0.6944 Remote Similarity NPD8053 Approved
0.6944 Remote Similarity NPD7309 Approved
0.6944 Remote Similarity NPD8054 Approved
0.6943 Remote Similarity NPD4140 Approved
0.6937 Remote Similarity NPD2161 Phase 2
0.6933 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6932 Remote Similarity NPD3751 Discontinued
0.6923 Remote Similarity NPD7243 Clinical (unspecified phase)
0.6914 Remote Similarity NPD3060 Approved
0.6908 Remote Similarity NPD5327 Phase 3
0.6905 Remote Similarity NPD7028 Phase 2
0.6897 Remote Similarity NPD3051 Approved
0.6897 Remote Similarity NPD6071 Discontinued
0.6897 Remote Similarity NPD7229 Phase 3
0.6894 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6894 Remote Similarity NPD3540 Phase 1
0.6894 Remote Similarity NPD1550 Clinical (unspecified phase)
0.689 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6889 Remote Similarity NPD4577 Approved
0.6889 Remote Similarity NPD4578 Approved
0.6887 Remote Similarity NPD422 Phase 1
0.6883 Remote Similarity NPD6584 Phase 3
0.6879 Remote Similarity NPD6233 Phase 2
0.6875 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6867 Remote Similarity NPD6516 Phase 2
0.6867 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6867 Remote Similarity NPD7526 Approved
0.6867 Remote Similarity NPD7527 Clinical (unspecified phase)
0.6867 Remote Similarity NPD5846 Approved
0.6867 Remote Similarity NPD52 Approved
0.6855 Remote Similarity NPD6353 Approved
0.6852 Remote Similarity NPD1549 Phase 2
0.6848 Remote Similarity NPD4357 Discontinued
0.6842 Remote Similarity NPD2563 Approved
0.6842 Remote Similarity NPD5402 Approved
0.6842 Remote Similarity NPD2560 Approved
0.6835 Remote Similarity NPD2238 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data